Cargando…

Crosstalk of RNA methylation writers defines tumor microenvironment and alisertib resistance in breast cancer

BACKGROUND: The five major RNA methylation modifications (m6A, m1A, m6Am, m5C, and m7G) exert biological roles in tumorigenicity and immune response, mediated mainly by “writer” enzymes. Here, the prognostic values of the “writer” enzymes and the TCP1 role in drug resistance in breast cancer (BC) we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Xiaoqiang, Shen, Li, Zhu, Yanhui, Zhai, Changyuan, Zeng, Hanling, Liu, Xiaoan, Tao, Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10561238/ https://www.ncbi.nlm.nih.gov/pubmed/37818090 http://dx.doi.org/10.3389/fendo.2023.1166939

Ejemplares similares

The crosstalk within the breast tumor microenvironment in type II diabetes: Implications for cancer disparities
por: Ennis, Christina S., et al.
Publicado: (2022)

Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment
por: Zhu, Yifei, et al.
Publicado: (2022)

Crosstalk Between Four Types of RNA Modification Writers Characterizes the Tumor Immune Microenvironment Infiltration Patterns in Skin Cutaneous Melanoma
por: Zhang, Shichao, et al.
Publicado: (2022)

Exercise improves subchondral bone microenvironment through regulating bone-cartilage crosstalk
por: Zhang, Shihua, et al.
Publicado: (2023)

Cross-talk of four types of RNA modification writers defines tumor microenvironment and pharmacogenomic landscape in colorectal cancer
por: Chen, Huifang, et al.
Publicado: (2021)

Comprehensive analysis of pyroptotic gene prognostic signatures associated with tumor immune microenvironment and genomic mutation in breast cancer
por: Zhang, Hongfei, et al.
Publicado: (2022)

Cardiomyocyte Senescence and Cellular Communications Within Myocardial Microenvironments
por: Tang, Xiaoqiang, et al.
Publicado: (2020)

The Tumor Microenvironment as a Regulator of Endocrine Resistance in Breast Cancer
por: Diaz Bessone, María Inés, et al.
Publicado: (2019)

Combining selinexor with alisertib to target the p53 pathway in neuroblastoma
por: Nguyen, Rosa, et al.
Publicado: (2022)

Chemoresistance: Intricate Interplay Between Breast Tumor Cells and Adipocytes in the Tumor Microenvironment
por: Mentoor, Ilze, et al.
Publicado: (2018)

Crosstalk of Inflammatory Cytokines within the Breast Tumor Microenvironment
por: Habanjar, Ola, et al.
Publicado: (2023)

Crosstalk of the Insulin-Like Growth Factor Receptor with the Wnt Signaling Pathway in Breast Cancer
por: Rota, Lauren M., et al.
Publicado: (2015)

RNA modification writers pattern in relation to tumor microenvironment and prognosis in prostate cancer
por: Cheng, Xu, et al.
Publicado: (2023)

Clinical value and feasibility of ISET in detecting circulating tumor cells in early breast cancer
por: Zeng, Hanling, et al.
Publicado: (2020)

Adipocyte-Endothelium Crosstalk in Obesity
por: Sabaratnam, Rugivan, et al.
Publicado: (2021)

ABCG2 impairs the activity of the aurora kinase inhibitor tozasertib but not of alisertib
por: Michaelis, Martin, et al.
Publicado: (2015)

The role of the tumor microenvironment in endocrine therapy resistance in hormone receptor-positive breast cancer
por: Yuan, Jie, et al.
Publicado: (2023)

Metabolomics-Microbiome Crosstalk in the Breast Cancer Microenvironment
por: Al-Ansari, Mysoon M., et al.
Publicado: (2021)

Exploration of the immune microenvironment of breast cancer in large population cohorts
por: Deng, Youyuan, et al.
Publicado: (2022)

Sustained and durable response with Alisertib monotherapy in the treatment of relapsed Atypical Teratoid Rhabdoid Tumor (ATRT)
por: Howden, Kaitlyn, et al.
Publicado: (2022)

Targets in Epigenetics: Inhibiting the Methyl Writers of the Histone Code
por: Yost, Julianne M, et al.
Publicado: (2011)

Cisplatin‐resistant cancer cells are sensitive to Aurora kinase A inhibition by alisertib
por: Wang, Lihong, et al.
Publicado: (2017)

A Phase II Trial of Alisertib (MLN8237) in Salvage Malignant Mesothelioma
por: Gay, Carl M., et al.
Publicado: (2020)

Population Pharmacokinetics and Exposure‐Safety Relationships of Alisertib in Children and Adolescents With Advanced Malignancies
por: Zhou, Xiaofei, et al.
Publicado: (2022)

Phase I trial to evaluate the addition of alisertib to fulvestrant in women with endocrine-resistant, ER+ metastatic breast cancer
por: Haddad, Tufia C., et al.
Publicado: (2017)

Choosing the right partner in hormone-dependent gene regulation: Glucocorticoid and progesterone receptors crosstalk in breast cancer cells
por: Pecci, Adali, et al.
Publicado: (2022)

Integrated tumor genomic and immune microenvironment analysis identifies predictive biomarkers associated with the efficacy of neoadjuvant therapy for triple‐negative breast cancer
por: Zhu, Yanhui, et al.
Publicado: (2022)

Editorial: Vascular and skeletal crosstalk in health and disease
por: Sharan, Kunal
Publicado: (2022)

The role of cellular crosstalk in the progression of diabetic nephropathy
por: Zhang, Keying, et al.
Publicado: (2023)

A functional crosstalk between the H3K9 methylation writers and their reader HP1 in safeguarding embryonic stem cell identity
por: Dong, Lixia, et al.
Publicado: (2023)

Crosstalk of necroptosis and pyroptosis defines tumor microenvironment characterization and predicts prognosis in clear cell renal carcinoma
por: Fu, Liangmin, et al.
Publicado: (2022)

Crosstalk of three novel types of programmed cell death defines distinct microenvironment characterization and pharmacogenomic landscape in breast cancer
por: Xu, Lijun
Publicado: (2022)

Crosstalk between Hypoxia and Extracellular Matrix in the Tumor Microenvironment in Breast Cancer
por: Dekker, Yasmin, et al.
Publicado: (2022)

Crosstalk between triple negative breast cancer and microenvironment
por: Smrekar, Karly, et al.
Publicado: (2023)

Editorial: Crosstalk of Mitochondria With Brain Insulin and Leptin Signaling
por: Kleinridders, André, et al.
Publicado: (2018)

Harnessing Muscle–Liver Crosstalk to Treat Nonalcoholic Steatohepatitis
por: Chakravarthy, Manu V., et al.
Publicado: (2020)

Muscle-Bone Crosstalk in Chronic Obstructive Pulmonary Disease
por: Zhang, Lijiao, et al.
Publicado: (2021)

The Adipose Tissue at the Crosstalk Between EDCs and Cancer Development
por: Bokobza, Emma, et al.
Publicado: (2021)

Editorial: Crosstalk between adipose tissue and immune cells
por: Seldin, Marcus M., et al.
Publicado: (2022)

Crosstalk between bone and muscle in chronic kidney disease
por: Wong, Limy, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ruq94fmnejisa4djr3tp89l5i2